These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 21111731)
1. p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury. Birukova AA; Zebda N; Cokic I; Fu P; Wu T; Dubrovskyi O; Birukov KG Exp Cell Res; 2011 Apr; 317(6):859-72. PubMed ID: 21111731 [TBL] [Abstract][Full Text] [Related]
2. Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids. Birukova AA; Zebda N; Fu P; Poroyko V; Cokic I; Birukov KG J Cell Physiol; 2011 Aug; 226(8):2052-62. PubMed ID: 21520057 [TBL] [Abstract][Full Text] [Related]
3. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids. Birukova AA; Malyukova I; Mikaelyan A; Fu P; Birukov KG J Cell Physiol; 2007 Jun; 211(3):608-17. PubMed ID: 17219408 [TBL] [Abstract][Full Text] [Related]
4. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607 [TBL] [Abstract][Full Text] [Related]
5. Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Birukova AA; Malyukova I; Poroyko V; Birukov KG Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L199-211. PubMed ID: 17513457 [TBL] [Abstract][Full Text] [Related]
6. Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability. Zebda N; Tian Y; Tian X; Gawlak G; Higginbotham K; Reynolds AB; Birukova AA; Birukov KG J Biol Chem; 2013 Jun; 288(25):18290-9. PubMed ID: 23653363 [TBL] [Abstract][Full Text] [Related]
7. Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids. Birukova AA; Fu P; Wu T; Dubrovskyi O; Sarich N; Poroyko V; Birukov KG J Cell Physiol; 2012 May; 227(5):1883-90. PubMed ID: 21732359 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids. Oskolkova O; Gawlak G; Tian Y; Ke Y; Sarich N; Son S; Andreasson K; Bochkov VN; Birukova AA; Birukov KG FASEB J; 2017 Sep; 31(9):4187-4202. PubMed ID: 28572443 [TBL] [Abstract][Full Text] [Related]
9. Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo. Nonas S; Birukova AA; Fu P; Xing J; Chatchavalvanich S; Bochkov VN; Leitinger N; Garcia JG; Birukov KG Crit Care; 2008; 12(1):R27. PubMed ID: 18304335 [TBL] [Abstract][Full Text] [Related]
10. Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium. Birukova AA; Fu P; Chatchavalvanich S; Burdette D; Oskolkova O; Bochkov VN; Birukov KG Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L924-35. PubMed ID: 17158600 [TBL] [Abstract][Full Text] [Related]
11. Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus. Meliton AY; Meng F; Tian Y; Sarich N; Mutlu GM; Birukova AA; Birukov KG Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L550-62. PubMed ID: 25575515 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine. Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609 [TBL] [Abstract][Full Text] [Related]
16. Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids. Birukova AA; Alekseeva E; Cokic I; Turner CE; Birukov KG Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L593-602. PubMed ID: 18676874 [TBL] [Abstract][Full Text] [Related]
17. Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC. Tian Y; Tian X; Gawlak G; Sarich N; Sacks DB; Birukova AA; Birukov KG Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L800-L809. PubMed ID: 27566003 [TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4. Ke Y; Zebda N; Oskolkova O; Afonyushkin T; Berdyshev E; Tian Y; Meng F; Sarich N; Bochkov VN; Wang JM; Birukova AA; Birukov KG Circ Res; 2017 Jul; 121(3):244-257. PubMed ID: 28522438 [TBL] [Abstract][Full Text] [Related]
19. Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses. Birukova AA; Shah AS; Tian Y; Moldobaeva N; Birukov KG Cell Signal; 2016 Jun; 28(6):541-51. PubMed ID: 26923917 [TBL] [Abstract][Full Text] [Related]
20. A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations. Birukova AA; Lee S; Starosta V; Wu T; Ho T; Kim J; Berliner JA; Birukov KG PLoS One; 2012; 7(1):e30957. PubMed ID: 22303475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]